Durability of Hepatitis B e Antigen Seroconversion in Chronic Hepatitis B Patients Treated with Entecavir or Tenofovir

Fong Tse-Ling; Tien Andy; Jo Kahee J.; Chu Danny; Cheung Eddie; Mena Edward A.; Quang-Quoc Phan; Yu Andy S.; Mohammed Wafa; Velasco Andrew; Vinh-Huy LeDuc; Nguyen Nickolas; Han Steven-Bui; Chang Mimi; Bae Ho S.; Cho Yong-Won; Tong Myron J.; Cooper Stewart L.

首页> 外文期刊>Digestive Diseases and Sciences >Durability of Hepatitis B e Antigen Seroconversion in Chronic Hepatitis B Patients Treated with Entecavir or Tenofovir

【24h】

Durability of Hepatitis B e Antigen Seroconversion in Chronic Hepatitis B Patients Treated with Entecavir or Tenofovir

机译：恩替卡韦或替诺福韦治疗的慢性乙型肝炎患者乙型肝炎抗原血清转换的持久性

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Loss of HBeAg and development of anti-HBe (seroconversion) is seen as a milestone and endpoint in the treatment of HBeAg-positive patients with chronic hepatitis B (CHB). Among patients treated with nucleos(t)ide analogs (NA), recurrent viremia is common after discontinuation of therapy. Entecavir (ETV) and tenofovir (TDF) are highly potent NA. The durability of virological response and HBeAg seroconversion in patients treated with these agents is not well studied.

机译：HBeAg的丧失和抗HBe的发展（血清转化）被视为治疗慢性乙型肝炎（CHB）的HBeAg阳性患者的一个里程碑和终点。在接受核苷酸（t）ide类似物（NA）治疗的患者中，停药后复发病毒血症很常见。恩替卡韦（ETV）和替诺福韦（TDF）是非常有效的NA。用这些药物治疗的患者的病毒学应答和HBeAg血清转化的持久性尚未得到很好的研究。

著录项

来源
《Digestive Diseases and Sciences》 |2015年第11期|共8页
作者
Fong Tse-Ling; Tien Andy; Jo Kahee J.; Chu Danny; Cheung Eddie; Mena Edward A.; Quang-Quoc Phan; Yu Andy S.; Mohammed Wafa; Velasco Andrew; Vinh-Huy LeDuc; Nguyen Nickolas; Han Steven-Bui; Chang Mimi; Bae Ho S.; Cho Yong-Won; Tong Myron J.; Cooper Stewart L.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类消化系及腹部疾病;
关键词
Remission; Relapse; Seroreversion;

机译：缓解;复发;逆转;

相似文献

外文文献
中文文献
专利

1. Durability of Hepatitis B e Antigen Seroconversion in Chronic Hepatitis B Patients Treated with Entecavir or Tenofovir [J] . Fong Tse-Ling, Tien Andy, Jo Kahee J., Digestive Diseases and Sciences . 2015,第11期

机译：恩替卡韦或替诺福韦治疗的慢性乙型肝炎患者乙型肝炎抗原血清转换的持久性
2. Seroconversion of Hepatitis B Virus Surface Antigen in Chronic Hepatitis B Child Treated with Entecavir [J] . Dong Li, Junping Wang, Junqing Zhou, North American Journal of Medical Sciences . 2012,第9期

机译：恩替卡韦治疗慢性乙型肝炎儿童的乙型肝炎病毒表面抗原的血清转化
3. Seroconversion of Hepatitis B Virus Surface Antigen in Chronic Hepatitis B Child Treated with Entecavir [J] . Dong Li, Junping Wang, Junqing Zhou, North American Journal of Medical Sciences . 2012,第9期

机译：恩替卡韦治疗慢性乙型肝炎儿童的乙型肝炎病毒表面抗原的血清转化
4. Genotype and Serotype Identification of Hepatitis B Virus in Chronic Hepatitis B Patients Treated with Telbivudine [C] . Y Purnamasari, Tien, Arimaswati, International Seminar on Smart Molecule of Natural Resources . 2020

机译：临床治疗慢性乙型肝炎患者乙型肝炎病毒的基因型和血清型鉴定
5. Incidence, Durability, and Clinical Outcomes of Hepatitis B Surface Antigen Seroclearance in Patients with Chronic Hepatitis B [D] . Yip, Cheuk Fung. 2019

机译：慢性乙型肝炎患者乙型肝炎表面抗原血管疮的发病率，耐久性和临床结果
6. Durability of Hepatitis B e Antigen Seroconversion in Chronic Hepatitis B Patients Treated with Entecavir or Tenofovir [O] . Tse-Ling Fong, Andy Tien, Kahee J. Jo, -1

机译：恩替卡韦或替诺福韦治疗的慢性乙型肝炎患者乙型肝炎抗原血清转换的持久性
7. Hepatitis B surface antigen quantification at hepatitis B e antigen seroconversion predicts virological relapse after the cessation of entecavir treatment in hepatitis B e antigen-positive patients [O] . Yuan-wang Qiu, Li-hua Huang, Wen-long Yang, 2016

机译：乙型肝炎e抗原血清学转换的乙型肝炎表面抗原定量预测乙型肝炎e抗原阳性患者停用恩替卡韦后病毒学复发

Durability of Hepatitis B e Antigen Seroconversion in Chronic Hepatitis B Patients Treated with Entecavir or Tenofovir

摘要

著录项

相似文献

相关主题

期刊订阅